PaRTNer: Patient Reported Outcomes and Financial Toxicity in Head and Neck Cancer A Pilot, Survey Based Study
PaRTNer
1 other identifier
interventional
60
1 country
1
Brief Summary
The purpose of this single institution, pilot study is to explore the out of pocket (OOP)costs and financial toxicity of cancer care for patients during definitive treatment of head and neck cancer with radiation therapy with or without chemotherapy and surgical resection. The study team will assess how the financial burden of cancer care impacts quality of life as well as treatment-related decision-making from a patient perspective.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable head-and-neck-cancer
Started Jun 2018
Longer than P75 for not_applicable head-and-neck-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 20, 2018
CompletedFirst Posted
Study publicly available on registry
April 24, 2018
CompletedStudy Start
First participant enrolled
June 19, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 29, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 13, 2026
CompletedMay 6, 2026
May 1, 2026
3.4 years
April 20, 2018
May 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Financial toxicity, as measured by out of pocket (OOP) costs for a definitive course of treatment for HNC
3 months post radiation therapy
Financial toxicity, as measured by out of pocket (OOP) costs for a definitive course of treatment for HNC
6 months post radiation therapy
Financial toxicity, as measured by change in Comprehensive Score for financial Toxicity (COST)
Financial toxicity will be measured using the comprehensive score for financial toxicity (COST). The range of the COST score is 0-44.
Baseline, 3 months post radiation therapy, 6 months post radiation therapy
Secondary Outcomes (3)
Change in symptom burden, as measured by Functional Assessment of Cancer Therapy-Head and Neck (FACT-H&N) score
Baseline, 3 months post radiation therapy, 6 months post radiation therapy
Change in quality of life, as measured by FACT-H&N score
Baseline, 3 months post radiation therapy, 6 months post radiation therapy
Perceived quality of care
3 months post radiation therapy, 6 months post radiation therapy
Other Outcomes (3)
Disease status
5 years post completion of radiation treatment
Overall survival
5 years post completion of radiation treatment
Progression free survival
5 years post completion of radiation treatment
Study Arms (1)
Single arm non-therapeutic interventional study
OTHERAll subjects who enroll on study will be asked to complete questionnaires at baseline before treatment starts; the questionnaires are repeated at one month, three and six months after radiation therapy has been completed. the demographics questionnaire is completed at baseline only; the FACT-HN is completed at all four time points.
Interventions
Patients will complete a baseline survey assessing socioeconomic household information, baseline symptoms, QOL, and financial toxicity, as well as attitudes toward cost conversations and educational handouts.
Eligibility Criteria
You may qualify if:
- Adult (18 years or older) patients
- Diagnosed with HNC with treatment plan including definitive radiation therapy or chemotherapy/radiation therapy
- Be able to read and write in English
- Able to give informed consent and complete survey materials
You may not qualify if:
- Recurrent disease
- Metastatic disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke Cancer Center
Durham, North Carolina, 27710, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pooja Karukonda, MD
Duke University Health System (DUHS)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 20, 2018
First Posted
April 24, 2018
Study Start
June 19, 2018
Primary Completion
November 29, 2021
Study Completion
April 13, 2026
Last Updated
May 6, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share